William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021
-
Adamas to Present at Upcoming William Blair Biotech Focus Conference
-
Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021
-
Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference
-
iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021
-
iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021
-
Pluralsight Completes Acquisition of A Cloud Guru to Accelerate its Push to Solve the Growing Cloud Skills Gap
-
Albireo to Present at the William Blair Biotech Focus Conference 2021
-
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
-
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
-
BeyondSpring to Participate in the William Blair Biotech Focus Conference
-
Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021
-
Vaccitech to Present at the William Blair Biotech Focus Conference 2021
-
ReCode Therapeutics to Present at William Blair Biotech Focus Conference 2021
-
Generation Bio to Present at William Blair Biotech Focus Conference
-
Generation Bio to Present at William Blair Biotech Focus Conference
-
9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference
-
Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021
-
Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference
-
Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
-
LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021
-
Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
-
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
-
Post-Fed taper tantrum? Not this time, market strategists say
-
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference
-
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference
-
Sera Prognostics (SERA) Announces 4.7M Share IPO at $15-$17/sh
-
Form D/A William Blair Macro Allo
-
Form D/A William Blair Internatio
-
Merus to Participate in William Blair's Biotech Focus Conference 2021
-
Merus to Participate in William Blair's Biotech Focus Conference 2021
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Kinnate Biopharma Inc. to Participate in the William Blair Biotech Focus Conference 2021
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021
-
Ramaco Resources, Inc. Announces Public Offering of Senior Unsecured Notes Due 2026
-
Eyenovia to Participate in Two Upcoming Investor Conferences
-
Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021
-
Stevanato Group Launches Roadshow for Proposed Initial Public Offering
-
Codiak BioSciences to Present at the Virtual William Blair Biotech Focus Conference 2021
-
Replimune to Present at the William Blair Biotech Focus Conference 2021
-
Jounce Therapeutics to Participate in William Blair’s Biotech Focus Conference
-
Aravive to Participate in Fireside Chat at 2021 William Blair Biotech Focus Conference
-
Icosavax Inc. (ICVX) Files up to $100M IPO
-
Vestar Capital Partners Acquires Stratus, a Global Leader in Brand Implementation and Facilities Services, from Arcapita
-
Crescendo to Participate in Upcoming Investor Events
-
Teads (TEAD) Files $100M IPO
-
Traeger (COOK) Files $100M IPO

